BIOMAT Database Logo BIOMAT Database Logo

Management of infectious pneumonia: value of C-reactive protein. 2009

Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012372 ROC Curve A graphic means for assessing the ability of a screening test to discriminate between healthy and diseased persons; may also be used in other studies, e.g., distinguishing stimuli responses as to a faint stimuli or nonstimuli. ROC Analysis,Receiver Operating Characteristic,Analysis, ROC,Analyses, ROC,Characteristic, Receiver Operating,Characteristics, Receiver Operating,Curve, ROC,Curves, ROC,ROC Analyses,ROC Curves,Receiver Operating Characteristics
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival
D017714 Community-Acquired Infections Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility. Community Acquired Infection,Community-Acquired Infection,Infections, Community-Acquired,Acquired Infection, Community,Acquired Infections, Community,Community Acquired Infections,Infection, Community Acquired,Infection, Community-Acquired,Infections, Community Acquired
D018410 Pneumonia, Bacterial Inflammation of the lung parenchyma that is caused by bacterial infections. Bacterial Pneumonia,Bacterial Pneumonias,Pneumonias, Bacterial

Related Publications

Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
The prognostic value of C-reactive protein for children with pneumonia.
March 2021, Acta paediatrica (Oslo, Norway : 1992),
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
[Value of C-reactive protein assay in severe infectious purpura in children].
November 1987, Presse medicale (Paris, France : 1983),
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
[C-reactive protein in infectious mononucleosis].
March 1958, Nordisk medicin,
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
[Clinical value of C reactive protein].
June 1957, La Riforma medica,
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia.
April 2010, International journal of STD & AIDS,
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
The value of C-reactive protein in the management of shunt infections.
September 2005, Journal of neurosurgery,
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
[Study of C-reactive protein in infectious psychoses].
January 1960, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia.
March 1978, The Journal of pediatrics,
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
The diagnostic value of C-reactive protein.
January 1983, Pediatric infectious disease,
Helder Gil, and Nadine Meaux Ruault, and Chafika Hafsaoui, and Jean-Louis Dupond, and Nadine Magy-Bertrand
Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia.
January 1995, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!